
---
import Layout from "@layouts/Layout.astro";
---

<Layout title="Research: Cancer Biology">

  <div class="flex items-cejnter gap-4 mb-6">
    <p class="text-justify leading-tight text-sm">
      <b>Gynecological cancers:</b> We apply multiomics integration methods to better understand 
      the tumor biology of gynecological cancers. In collaboration with 
      NCI's Clinical Tumor Analysis Consortyium (CPTAC) we have described the 
      proteogenomic landscape of endometrial cancer (EC)
      (<i><u><a href="https://doi.org/10.1016/j.cell.2020.01.026" target="_blank">Dou & Kawaler et al. Cell 2020</a></u></i>,
      <i><u><a href="https://doi.org/10.1016/j.ccell.2023.07.007" target="_blank">Dou & Katsnelson et al. Cancer Cell 2023</a></u></i>), and
      Ovarian Cancer (OV)
      (<i><u><a href="https://doi.org/10.1016/j.cell.2016.05.069" target="_blank">Zhang et al., Cell 2016</a></u></i>).
      We have integrated proteogenomics with histopathology imaging data using deep learning 
      (<i><u><a href="https://doi.org/10.1016/j.xcrm.2021.100400" target="_blank">Hong et al. Cell Reports Medicine 2021</a></u></i>.
      We have investigated the role of retrotransposons in EC and OV tumor biology and 
      its relationship to p53 mutation, copy number alteration, and S phase checkpoint
      (<i><u><a href="https://doi.org/10.1073/pnas.2115999119" target="_blank">McKerrow et al. PNAS 2021</a></u></i>). 
      We are also investigating the relayionship between the tumor microenvironment and 
      the success of immune checkpoint inhibition therapy in endometrial and cervical cancer using 
      mspatial omics approaches.

    </p>
    <div class="flex-none">
    </div>
  </div>

  <div class="flex items-cejnter gap-4 mb-6">
    <div class="flex-none">
    </div>
    <p class="text-justify leading-tight text-sm">
      <b>Lung Cancer:</b> We are applying multi-omics integration methods and deep learning to investigate lung adenocarcinoma
      (<i><u><a href="https://doi.org/10.1016/j.cell.2020.06.013" target="_blank">Gillette al., Cell 2020</a></u></i>), lung squamous cell carcinoma 
      (<i><u><a href="https://doi.org/10.1016/j.cell.2021.07.016" target="_blank">Satpathy et al., Cell 2021</a></u></i>), and
lung small cell carcinoma.
    </p>
  </div>

  
  <div class="flex items-cejnter gap-4 mb-6">
    <p class="text-justify leading-tight text-sm">
      In collaboration with the Clinical Tumor Analysis Consortyium (CPTAC) 
      and the International Cancer Proteogenome Consortium (ICPC), we apply 
      multiomics integration methods to define the proteomic landscape with the goal o better understanding the tumor biology across tumor types: 
<b>Breast Cancer</b> (<i><u><a href="https://doi.org/10.1038/nature18003" target="_blank">Mertins et al., Nature 2016</a></u></i>, <i><u><a href="https://linkinghub.elsevier.com/retrieve/pii/S0092-8674(20)31400-8" target="_blank">Krug et al., Cell 2020</a></u></i>),
<b>Melanoma</b> (<i><u><a href="https://doi.org/10.1101/2023.09.29.559755" target="_blank">Kuras et al., bioRxixv2023</a></u></i>).
We are also exploring the similarities between cancer types through
<b>pan-camcer analysis:</b> integration of proteome comics with histology using deep learning (<i><u><a href="https://doi.org/10.1016/j.xcrm.2023.101173" target="_blank">Wang et al., Cell Reports Medicine 2023</a></u></i>) and exploration of the immune landscape (<i><u><a href="https://doi.org/10.1016/j.cell.2024.01.027" target="_blank">Petralia et al., Cell 2024</a></u></i>)

    </p>
    <div class="flex-none">
    </div>
  </div>

</Layout>
